Insights

Analysis, not news. Board-level briefings, deep-dive thinking, and weekly cyber intelligence for executives making high-stakes decisions.

AI Security Governance: Moving Beyond the Hype

Boards are being told that AI represents both unprecedented opportunity and existential risk. The reality is more nuanced. As AI systems move from experimentation to operational deployment, the governance challenge is less about the technology itself and more about how organizations make decisions under uncertainty. This analysis examines what boards actually need to know about AI security governance in regulated environments.

Read full analysis →

Recent Analysis

Cyber Due Diligence Beyond the Checklist

What private equity and corporate acquirers actually need to know when assessing cyber risk in complex transactions. Technical debt, integration challenges, and hidden liabilities that materially affect deal value.

Read more →

Medical Device Security in the Age of Connected Care

How MedTech companies are navigating the convergence of patient safety, regulatory compliance, and cyber security as medical devices become increasingly connected and software-defined.

Read more →

What Boards Should Actually Ask About Cyber Security

Moving beyond compliance theatre. The questions boards need to ask to understand real cyber risk, the answers they should expect, and when to challenge what they're being told.

Read more →

Securing Advanced Manufacturing: Lessons from High-Performance Environments

What Formula 1 and advanced manufacturing can teach us about operational technology security, incident response, and maintaining competitive advantage through continuous improvement.

Read more →

Weekly Cyber Roundup

A weekly digest of cyber and AI risk developments that actually affect decision-making at board and C-suite level. Signal, not noise. Delivered every Monday.

This Week's Intelligence

Week ending 7 February 2026

  • Regulatory Development: FDA publishes final guidance on cybersecurity in medical devices. Key implications for MedTech companies and what boards need to know about compliance timelines.
  • Threat Intelligence: Sophisticated supply chain compromise targeting Life Sciences R&D. Attribution points to state-sponsored actors. Impact assessment and mitigation strategies.
  • AI Governance: EU AI Act enforcement begins. What this means for organizations deploying AI in regulated environments and the practical governance implications for boards.
  • M&A Trend: Cyber risk increasingly cited as deal-breaker in PE transactions. Analysis of recent diligence failures and what this means for target companies.
  • Operational Security: Major OT security incident in automotive manufacturing. Lessons on resilience, incident response, and supply chain risk management.

Subscribe to receive the Weekly Cyber Roundup directly. Get in touch to join the distribution list.